Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial

Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial

IntroductionRespiratory, gastrointestinal, and allergic diseases can significantly impact both the physical and mental health of children, affecting their overall quality of life. This study aimed to evaluate the preventive effects and safety of Bifidobacterium longum subsp. infantis YLGB-1496 in re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xi Zhang, Ke Chen, Hanglian Lan, Haixia Chen, Hua Chen, Ping Yang, Nianyang He, Weilian Hung, Zaozhong Zeng, Changqi Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Nutrition
Subjects:	probiotics short chain fatty acids children gut microbiota upper respiratory tract infection
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2025.1585504/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correction: Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial
by: Xi Zhang, et al.
Published: (2025-08-01)

Clinical effects of Bifidobacterium Longum Subsp. Infantis YLGB-1496 on children with respiratory symptoms
by: Pin Li, et al.
Published: (2025-02-01)

Indole Derivatives Biosynthesis in Bifidobacterium longum subsp. infantis and the Tryptophan Substrate Availability
by: Shi‐Min Zhang, et al.
Published: (2025-06-01)

Protective effects of Bifidobacterium longum subsp. longum BL21 against cyclophosphamide-induced reproductive dysfunction in zebrafish
by: Yao Dong, et al.
Published: (2025-04-01)

Uptake of fucosylated type I human milk oligosaccharide blocks by Bifidobacterium longum subsp. infantis
by: Morten Ejby Hansen, et al.
Published: (2025-08-01)

Selection and in vitro Probiotic Properties of Bifidobacterium longum subsp. longum with Anti-diabetic Activity from the Intestinal Tract of Chinese Tajik Children
by: LI Si, AN Meiling, LI Longlong, ZHANG Ruirui, SUN Hailong, NI Yongqing
Published: (2025-05-01)

Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01)

Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01)

Antibiotic Resistance in <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> and <i>Bifidobacterium longum</i>: Definition of Sensitivity/Resistance Profiles at the Species Level
by: Mario Terlizzi, et al.
Published: (2025-07-01)

Stress Resistance of Biofilm-type Bifidobacterium longum subsp. longum and Its Effect on Intestinal Microbiota
by: Shuang YAN, et al.
Published: (2025-08-01)

Bifidobacterium longum subsp. infantis CCFM1269 promotes intestinal barrier and release of IFN-β through TLR4-TRIF dependent way in growing mice
by: Mengfan Ding, et al.
Published: (2025-01-01)

Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Meina Li, et al.
Published: (2025-08-01)

Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01)

Propionibacterium freudenreichii co-inoculation enhances Bifidobacterium longum subsp. longum BB536 growth and metabolite content in soy whey
by: Ricco Tindjau, et al.
Published: (2025-09-01)

Effect of inulin on the growth and survival of Bifidobacterium longum BB536 in fermented goat’s and cow’s milk
by: Marina Šimunek, et al.
Published: (2009-09-01)

Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice
by: Xihua Yu, et al.
Published: (2025-07-01)

Bifidobacterium longum subsp. longum dipro-O: a potential therapeutic agent for ameliorating metabolic disorders in high-fat diet-induced obesity mouse model
by: Ning Xu, et al.
Published: (2025-06-01)

<i>Lactobacillus helveticus R0052</i> and <i>Bifidobacterium longum R0175</i> Supplementation: An Exploratory, Randomized, Placebo-Controlled Trial of Endocannabinoid and Inflammatory Responses in Female Dancers
by: Jakub Wiącek, et al.
Published: (2025-05-01)

Understanding the probiotic health benefits of Bifidobacterium animalis subsp. lactis, BB-12™
by: Fergus W. J. Collins, et al.
Published: (2025-07-01)

The impact of ingestion of Bifidobacterium longum NCC3001 on perinatal anxiety and depressive symptoms: a randomized controlled trial
by: Lisa R. Fries, et al.
Published: (2025-04-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Development of healthy whey drink with Lactobacillus rhamnosus, Bifidobacterium bifidum and Propionibacterium freudenreichii subsp. shermanii
by: T.K. Maity, et al.
Published: (2008-12-01)

Some Properties of Probiotic Yoghurt Produced for Babies by Adding Fruit Puree, Containing B. infantis, B. bifidum, B. longum, L. paracasei
by: Didem Sözeri Atik, et al.
Published: (2021-11-01)

Probiotic properties of an indigenous strain composition of <i>Bifidobacterium bifidum</i> ICIS-310 and <i>Bifidobacterium longum</i> ICIS-505 <i>in vitro</i>
by: N. B. Perunova, et al.
Published: (2025-06-01)

Role of Bifidobacterium animalis subsp. lactis BB-12 in mice with acute pancreatitis
by: Bingbing Du, et al.
Published: (2025-04-01)

Interactions between the human milk oligosaccharide 2′-fucosyllactose and Bifidobacterium longum subspecies infantis in influencing systemic immune development and function in piglets
by: Victoria C. Daniels, et al.
Published: (2024-10-01)

Probiotic Bifidobacterium longum Subsp. longum 51A Protects Mice from Genotoxic and Metabolic Alterations Induced by Subchronic Exposure to a Low-Dose Pesticide Cocktail
by: Mirna Maciel d’Auriol Souza, et al.
Published: (2025-08-01)

Effects of phototherapy combined with Lactobacillus salivarius AP-32 or Bifidobacterium animalis subsp. lactis CP-9 on improving neonatal jaundice and gut microbiome health: a randomized double-blind clinical study
by: Ming-Luen Tsai, et al.
Published: (2025-05-01)

Scientific Opinion on the substantiation of a health claim related to a combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) and decreasing potentially pathogenic intestinal microorganisms pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2009-12-01)

A double blinded randomized placebo trial of Bifidobacterium animalis subsp. lactis BLa80 on sleep quality and gut microbiota in healthy adults
by: Yinhua Liu, et al.
Published: (2025-04-01)

Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
by: Shunyu Yao, et al.
Published: (2021-01-01)

Comparative in silico analyses between Lactiplantibacillus plantarum and Bifidobacterium longum concerning probiotic properties, anti-lipidemic, and anti-diabetic in vitro activities
by: Asmaa Negm El-Dein, et al.
Published: (2025-06-01)

Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11
by: Alexander Bertuccioli, et al.
Published: (2025-05-01)

The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial
by: Ida Marie Bruun Grønbæk, et al.
Published: (2025-04-01)

Effect of Bifidobacterium animalis subsp. lactis Langg JZ-08 on lipid metabolism in individuals with obesity and dyslipidemia: A randomised, double-blind, and placebo-controlled trial
by: Xiaokang Niu, et al.
Published: (2025-06-01)

Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
by: Zhifeng Fang, et al.
Published: (2022-12-01)

Bifidobacterium animalis subsp. lactis A6 alleviates perennial allergic rhinitis in adults by inhibiting serum total IgE and IL‐13: A randomized, double‐blind, placebo‐controlled trial
by: Langrun Wang, et al.
Published: (2025-06-01)

Effect of Bifidobacterium Probiotic in the Treatment of Giardiasis Infection in Mice
by: Israa Mohammad Abd AL-Khaliq
Published: (2019-12-01)

Determination of Probiotic Viability in Yoghurts Produced with Acid Adapted Lactobacillus acidophilus ATCC 4356 and Bifidobacterium bifidum ATCC 11863 During Refrigerated Storage
by: Şehriban Oğuz, et al.
Published: (2023-12-01)

Bifidobacterium animalis subsp. Lactis BX-BC08 modulates gut microbiota and secretes alpha-Ketoglutaric acid to alleviate MC903-induced atopic dermatitis
by: Jiamin Zhao, et al.
Published: (2025-07-01)